Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
Mealy MA, Levy M
J Neuroimmunol. 2015 Oct 15; 287:29-30. Epub 2015 Aug 07. PMID: 26439958.Abstract